SBIR/STTR Research Award
Development of a Novel Agent for Alcohol Dependence
Award amount
$115,007Program and phase
SBIR · Phase IAward year
2003Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- THIOPHARMA, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant): Studies are proposed to complete the development of S-methyl N, Ndiethylthiolcarbamate sulfoxide (DETC-MeSO), a novel agents for the treatment of alcohol dependence. Specifically the following studies will be performed.
1. Complete the process chemistry development for DETC-MeSO and its
Isomers. (carried out at Thiopharma, Inc)
2. Synthesize sufficient scale UP quantities for preclinical toxicology
studies. (carried out at Pharm-Eco Laboratories, Inc)
3. Carry out pharmacokinetic studies in rats to support preclinical
toxicology studies. (carried out at The University of Kansas)
4. Preclinical toxicology studies in rats and dogs. (carried out at
Battelle).
Technology keywords
Not reported